A Study to Assess PV-10 Chemoablation of Cancer of the Liver

2014-08-27 03:18:58 | BioPortfolio


This open-label study will evaluate the safety, tolerability, pharmacokinetics and effect on tumor growth following a single intralesional injection of PV-10 in subjects with either recurrent hepatocellular carcinoma (HCC) or cancer metastatic to the liver. In each of two planned dose cohorts there will be three subjects. Dose escalation will occur following assessment of safety and tolerability in the first cohort.

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Cancer Metastatic to the Liver


PV-10 (10% rose bengal disodium)


Sharp Memorial Hospital
San Diego
United States




Provectus Pharmaceuticals

Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:18:58-0400

Clinical Trials [4711 Associated Clinical Trials listed on BioPortfolio]

A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver

This study is intended to determine the safety, tolerability and reduction of biochemical markers (Chromogranin A or, if deemed appropriate, 5-hydroxyindoleaceticacid) and troublesome symp...

Intralesional PV-10 Chemoablation of Metastatic Melanoma

The objective of this study is to investigate the safety of intralesional (IL) PV-10 for the treatment of metastatic melanoma. This study will also include a preliminary assessment of res...

Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

The primary objective of this study is to investigate the effectiveness of intralesional (IL) PV-10 for locoregional treatment of metastatic melanoma. This study will also include assessme...

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

This pilot clinical trial studies magnetic resonance imaging (MRI) with gadoxetate disodium in measuring tumors in patients with liver cancer. Diagnostic procedures, such as MRI with gadox...

PV-10 Chemoablation of Recurrent Breast Carcinoma

The objective of this study is to investigate the safety of intralesional (IL) PV-10 for the treatment of recurrent breast carcinoma. This study will also include a preliminary assessment...

PubMed Articles [17617 Associated PubMed Articles listed on BioPortfolio]

Combined treatment of colorectal cancer followed by metastatic liver injury.

To increase the effectiveness of treatment of colorectal cancer followed by metastatic liver lesion.

Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors.

Despite the amelioration of systemic therapy, overall survival (OS) of metastatic gastric cancer (GC) patients remains poor. Liver is a common metastatic site and retrospective series suggest a potent...

An ultrasensitive photoelectrochemical biosensor based on Ru(dcbpy)dppz/Rose Bengal dyes co-sensitized fullerene for DNA detection.

Though preferable progresses have been achieved to improve the photoelectric performance of fullerene (C NPs) by sensitized structure in photoelectrochemical (PEC) field, further application inevitabl...

Oxaliplatin-Induced Liver Changes on Gadoxetate Disodium-Enhanced Liver MRI.

Targeting high expressed α5β1 integrin in liver metastatic lesions to resist metastasis of colorectal cancer by RPM peptide modified chitosan-stearic micelles.

Liver metastasis is a leading death cause in colorectal cancer. The pathological differences between orthotopic tumors and metastatic lesions increased the therapeutic difficulty of metastasis. Herein...

Medical and Biotech [MESH] Definitions

A bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid.

Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.

Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%-40% of metastatic cancers to the ovaries and possibly 1%-2% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1685)

Tumors or cancer of the LIVER.

An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)

More From BioPortfolio on "A Study to Assess PV-10 Chemoablation of Cancer of the Liver"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Searches Linking to this Trial